Louis Breton

Louis Breton is an accomplished biotechnology executive with extensive leadership experience in various companies. Currently serving as CEO and Co-Founder of Rampart Bioscience since January 2020, Louis has previously held CEO roles at ARC Technologies Consulting and Calimmune, Inc. (acquired by CSL). Louis co-founded CellzDirect, Inc. and served as its CEO until its acquisition by Invitrogen. Earlier in career, Louis contributed to business development as a founding member at ICS and led Breton International Consulting as Owner/President before its acquisition. Louis has also held roles in marketing and business coaching, as well as academic positions including Assistant Professor at the University of Arizona. Educational background includes a Bachelor's Degree in Molecular and Cellular Biology from the University of Arizona and studies at the University of Pennsylvania and the Keck School of Medicine of the University of Southern California.